Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

India · Delayed Price · Currency is INR

1,805.30

-13.00 (-0.71%)

At close: Dec 5, 2025

Revenue

Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2013 - 2020
India Formulations Revenue	179.69B	169.23B	Log In	Log In	Log In	Upgrade
US Formulations Revenue	163.97B	162.40B	Log In	Log In	Log In	Upgrade
Emerging Market Revenue	99.84B	94.16B	Log In	Log In	Log In	Upgrade
Rest of the World Formulations Revenue	78.33B	71.63B	Log In	Log In	Log In	Upgrade
Total Formulations Revenue	521.84B	497.42B	Log In	Log In	Log In	Upgrade
Active Pharmaceutical Ingredients (API) Revenue	20.71B	21.29B	Log In	Log In	Log In	Upgrade
Others Segment Revenue	1.89B	1.70B	Log In	Log In	Log In	Upgrade
Other Operating Revenue	5.20B	5.37B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2013 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	2013 - 2020
Number of Medical Representatives	15.11K	Log In	Log In	Log In	Upgrade
Sales per Medical Representative	11.20M	Log In	Log In	Log In	Upgrade